These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 32528403

  • 1. Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With "Genuine" Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF.
    Orvieto R, Kirshenbaum M, Galiano V, Elkan-Miller T, Zilberberg E, Haas J, Nahum R.
    Front Endocrinol (Lausanne); 2020; 11():182. PubMed ID: 32528403
    [Abstract] [Full Text] [Related]

  • 2. A Novel Stimulation Protocol for Poor-Responder Patients: Combining the Stop GnRH-ag Protocol with Letrozole Priming and Multiple-Dose GnRH-ant: A Proof of Concept.
    Orvieto R, Nahum R, Aizer A, Haas J, Kirshenbaum M.
    Gynecol Obstet Invest; 2021; 86(1-2):149-154. PubMed ID: 33761501
    [Abstract] [Full Text] [Related]

  • 3. Stop GnRH-Agonist Combined with Multiple-Dose GnRH-Antagonist for Patients with Elevated Peak Serum Progesterone Levels Undergoing Ovarian Stimulation for IVF: A Proof of Concept.
    Orvieto R, Kirshenbaum M, Galiano V, Zilberberg E, Haas J, Nahum R.
    Gynecol Obstet Invest; 2020; 85(4):357-361. PubMed ID: 32580194
    [Abstract] [Full Text] [Related]

  • 4. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A, Tsur A, Haas J, Yerushalmi GM, Hourvitz A, Machtinger R, Orvieto R.
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [Abstract] [Full Text] [Related]

  • 5. Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection in Patients With "Unpredictable" Poor Response to Gonadotropin-Releasing Hormone Antagonist Protocol.
    Zhang C, Wu F, Wu Z, Sun B, Chen C, Qian W.
    Front Endocrinol (Lausanne); 2021 Jun; 12():739773. PubMed ID: 34707571
    [Abstract] [Full Text] [Related]

  • 6. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R, Nahum R, Zohav E, Liberty G, Anteby EY, Meltcer S.
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [Abstract] [Full Text] [Related]

  • 7. Co-administration of GnRH-agonist and hCG (double trigger) for final oocyte maturation increases the number of top-quality embryos in patients undergoing IVF/ICSI cycles.
    Tu B, Zhang H, Chen L, Yang R, Liu P, Li R, Qiao J.
    J Ovarian Res; 2024 Jul 03; 17(1):137. PubMed ID: 38961417
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S, Chen XN, Qiao J, Liu P, Li R, Chen GA, Ma CH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr 03; 47(4):245-9. PubMed ID: 22781108
    [Abstract] [Full Text] [Related]

  • 9. Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study.
    Haas J, Zilberberg E, Nahum R, Mor Sason A, Hourvitz A, Gat I, Orvieto R.
    Gynecol Endocrinol; 2019 Jul 03; 35(7):628-630. PubMed ID: 30810400
    [Abstract] [Full Text] [Related]

  • 10. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
    Orvieto R.
    J Ovarian Res; 2015 Nov 04; 8():69. PubMed ID: 26536862
    [Abstract] [Full Text] [Related]

  • 11. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R, Kruchkovich J, Rabinson J, Zohav E, Anteby EY, Meltcer S.
    Fertil Steril; 2008 Jul 04; 90(1):228-30. PubMed ID: 17681292
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
    Mohsen IA, El Din RE.
    Gynecol Endocrinol; 2013 Feb 04; 29(2):105-8. PubMed ID: 23134528
    [Abstract] [Full Text] [Related]

  • 16. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM.
    Fertil Steril; 2013 Nov 04; 100(5):1296-302. PubMed ID: 23993928
    [Abstract] [Full Text] [Related]

  • 17. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG, Sfontouris IA, Venetis CA, Lainas GT, Zorzovilis IZ, Tarlatzis BC, Kolibianakis EM.
    Hum Reprod; 2015 Oct 04; 30(10):2321-30. PubMed ID: 26307091
    [Abstract] [Full Text] [Related]

  • 18. Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves in vitro fertilisation outcomes in poor ovarian responders.
    Mutlu I, Demirdag E, Cevher F, Erdem A, Erdem M.
    J Obstet Gynaecol; 2022 Jul 04; 42(5):1239-1244. PubMed ID: 34565274
    [Abstract] [Full Text] [Related]

  • 19. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels.
    Orvieto R, Nahum R, Meltzer S, Liberty G, Anteby EY, Zohav E.
    Gynecol Endocrinol; 2013 Sep 04; 29(9):843-5. PubMed ID: 23802563
    [Abstract] [Full Text] [Related]

  • 20. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C.
    Fertil Steril; 2008 Jan 04; 89(1):84-91. PubMed ID: 17462639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.